OptiNose Long Term Debt vs Net Debt Analysis

OPTN Stock  USD 0.54  0.04  8.00%   
OptiNose financial indicator trend analysis is much more than just breaking down OptiNose prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether OptiNose is a good investment. Please check the relationship between OptiNose Long Term Debt and its Net Debt accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OptiNose. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.

Long Term Debt vs Net Debt

Long Term Debt vs Net Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of OptiNose Long Term Debt account and Net Debt. At this time, the significance of the direction appears to have almost no relationship.
The correlation between OptiNose's Long Term Debt and Net Debt is 0.12. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Net Debt in the same time period over historical financial statements of OptiNose, assuming nothing else is changed. The correlation between historical values of OptiNose's Long Term Debt and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of OptiNose are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Long Term Debt i.e., OptiNose's Long Term Debt and Net Debt go up and down completely randomly.

Correlation Coefficient

0.12
Relationship DirectionPositive 
Relationship StrengthInsignificant

Long Term Debt

Long-term debt is a debt that OptiNose has held for over one year. Long-term debt appears on OptiNose balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on OptiNose balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.
Most indicators from OptiNose's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into OptiNose current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OptiNose. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.As of the 4th of December 2024, Selling General Administrative is likely to drop to about 78.7 M. Issuance Of Capital Stock is expected to grow at the current pace this year
 2021 2022 2023 2024 (projected)
Depreciation And Amortization646K532K402K611.7K
Interest Income52K513K2.5M2.7M

OptiNose fundamental ratios Correlations

0.760.640.370.560.280.950.880.81-0.48-0.580.780.980.540.50.520.740.980.50.580.310.740.560.630.730.67
0.760.970.75-0.040.70.590.480.750.13-0.930.670.620.630.620.620.990.620.890.870.710.990.420.410.960.99
0.640.970.72-0.180.70.460.40.660.27-0.940.590.470.640.630.510.960.470.950.830.720.960.450.350.970.98
0.370.750.72-0.490.910.160.070.490.53-0.90.290.240.370.380.620.730.240.70.950.970.73-0.260.210.740.79
0.56-0.04-0.18-0.49-0.560.760.750.32-0.990.330.340.690.130.080.03-0.040.69-0.31-0.3-0.56-0.040.470.42-0.06-0.18
0.280.70.70.91-0.560.05-0.070.450.62-0.860.390.130.120.140.620.680.130.750.910.910.68-0.160.090.670.75
0.950.590.460.160.760.050.940.72-0.7-0.360.680.980.440.390.410.580.980.270.380.090.580.540.650.570.47
0.880.480.40.070.75-0.070.940.63-0.7-0.290.620.920.430.370.260.470.920.180.280.060.470.540.790.540.37
0.810.750.660.490.320.450.720.63-0.25-0.630.560.750.450.420.880.750.750.560.640.440.750.360.450.720.7
-0.480.130.270.53-0.990.62-0.7-0.7-0.25-0.41-0.25-0.63-0.08-0.030.010.12-0.630.410.370.60.12-0.39-0.390.140.26
-0.58-0.93-0.94-0.90.33-0.86-0.36-0.29-0.63-0.41-0.51-0.42-0.51-0.51-0.59-0.91-0.42-0.89-0.97-0.9-0.91-0.16-0.33-0.93-0.96
0.780.670.590.290.340.390.680.620.56-0.25-0.510.720.320.280.360.630.720.560.50.270.630.620.610.620.61
0.980.620.470.240.690.130.980.920.75-0.63-0.420.720.440.390.460.61.00.30.450.180.60.510.640.580.5
0.540.630.640.370.130.120.440.430.45-0.08-0.510.320.441.00.270.610.440.620.380.250.610.380.320.650.64
0.50.620.630.380.080.140.390.370.42-0.03-0.510.280.391.00.260.590.390.630.370.260.590.340.280.630.63
0.520.620.510.620.030.620.410.260.880.01-0.590.360.460.270.260.640.460.50.660.550.64-0.030.240.570.61
0.740.990.960.73-0.040.680.580.470.750.12-0.910.630.60.610.590.640.60.870.850.691.00.410.410.960.98
0.980.620.470.240.690.130.980.920.75-0.63-0.420.721.00.440.390.460.60.30.450.180.60.510.640.580.5
0.50.890.950.7-0.310.750.270.180.560.41-0.890.560.30.620.630.50.870.30.780.680.870.380.170.880.93
0.580.870.830.95-0.30.910.380.280.640.37-0.970.50.450.380.370.660.850.450.780.940.85-0.010.330.860.89
0.310.710.720.97-0.560.910.090.060.440.6-0.90.270.180.250.260.550.690.180.680.940.69-0.230.260.730.76
0.740.990.960.73-0.040.680.580.470.750.12-0.910.630.60.610.590.641.00.60.870.850.690.410.410.960.98
0.560.420.45-0.260.47-0.160.540.540.36-0.39-0.160.620.510.380.34-0.030.410.510.38-0.01-0.230.410.270.370.36
0.630.410.350.210.420.090.650.790.45-0.39-0.330.610.640.320.280.240.410.640.170.330.260.410.270.530.35
0.730.960.970.74-0.060.670.570.540.720.14-0.930.620.580.650.630.570.960.580.880.860.730.960.370.530.96
0.670.990.980.79-0.180.750.470.370.70.26-0.960.610.50.640.630.610.980.50.930.890.760.980.360.350.96
Click cells to compare fundamentals

OptiNose Account Relationship Matchups

OptiNose fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets172.7M188.8M166.1M144.2M107.7M158.3M
Short Long Term Debt Total75.7M127.3M130.7M131.2M130.2M94.0M
Other Current Liab31.4M44.6M49.1M42.9M42.4M29.8M
Total Current Liabilities36.1M52.2M59.2M178.7M176.5M185.4M
Total Stockholder Equity61.6M6.8M(21.8M)(56.6M)(86.6M)(82.3M)
Net Tangible Assets61.6M6.8M(21.8M)(56.6M)(65.1M)(61.9M)
Property Plant And Equipment Net3.1M2.0M1.3M795K815K1.3M
Net Debt(72.6M)(19.0M)20.2M36.9M56.5M59.4M
Retained Earnings(428.0M)(527.8M)(610.1M)(684.9M)(720.4M)(684.4M)
Accounts Payable3.6M5.5M8.0M5.3M3.9M5.6M
Cash147.1M144.2M110.5M94.2M73.7M129.3M
Non Current Assets Total25.5M44.7M5.7M50.0M2.4M2.3M
Non Currrent Assets Other22.5M42.6M4.3M49.2M1.6M1.5M
Other Assets152K155K294K498K572.7K317.1K
Long Term Debt72.5M74.5M125.2M126.4M145.4M78.6M
Cash And Short Term Investments147.1M144.2M110.5M94.2M73.7M129.3M
Net Receivables13.8M23.4M35.4M33.9M19.9M16.1M
Common Stock Total Equity46K53K82K111K127.7K134.0K
Common Stock Shares Outstanding41.9M48.3M56.9M85.9M112.1M117.7M
Long Term Debt Total72.5M74.5M125.2M126.4M145.4M78.6M
Liabilities And Stockholders Equity172.7M188.8M166.1M144.2M107.7M158.3M
Non Current Liabilities Total74.9M129.9M128.6M22.1M17.8M16.9M
Other Current Assets3.6M4.1M2.6M2.9M3.7M4.2M
Other Stockholder Equity489.6M534.6M588.3M628.2M633.7M420.0M
Total Liab111.1M182.0M187.8M200.8M194.3M140.5M
Property Plant And Equipment Gross3.1M2.0M5.6M5.4M5.7M3.5M
Total Current Assets147.1M144.2M160.4M94.2M105.3M139.8M
Accumulated Other Comprehensive Income(48K)(85K)(81K)(84K)(96.6K)(101.4K)
Common Stock46K53K82K111K112K60.0K
Property Plant Equipment4.4M2.0M1.3M795K914.3K868.5K
Inventory3.5M9.0M11.8M9.4M8.1M7.2M
Non Current Liabilities Other397K4.7M2.2M22.1M25.4M26.7M
Capital Surpluse489.6M534.6M588.3M628.2M722.5M557.9M
Net Invested Capital136.1M132.0M104.6M72.0M43.6M41.4M
Net Working Capital131.9M128.5M101.1M(38.2M)(71.2M)(67.6M)

Pair Trading with OptiNose

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OptiNose position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OptiNose will appreciate offsetting losses from the drop in the long position's value.

Moving together with OptiNose Stock

  0.71VRAX Virax Biolabs GroupPairCorr

Moving against OptiNose Stock

  0.81ETON Eton Pharmaceuticals Downward RallyPairCorr
  0.7VRNA Verona Pharma PLCPairCorr
  0.61EWTX Edgewise TherapeuticsPairCorr
  0.49ELDN Eledon PharmaceuticalsPairCorr
  0.31DSGN Design TherapeuticsPairCorr
The ability to find closely correlated positions to OptiNose could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OptiNose when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OptiNose - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OptiNose to buy it.
The correlation of OptiNose is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OptiNose moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OptiNose moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OptiNose can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether OptiNose offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OptiNose's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Optinose Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Optinose Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OptiNose. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OptiNose. If investors know OptiNose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OptiNose listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.29)
Revenue Per Share
0.553
Quarterly Revenue Growth
0.031
Return On Assets
(0.10)
Return On Equity
(10.51)
The market value of OptiNose is measured differently than its book value, which is the value of OptiNose that is recorded on the company's balance sheet. Investors also form their own opinion of OptiNose's value that differs from its market value or its book value, called intrinsic value, which is OptiNose's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OptiNose's market value can be influenced by many factors that don't directly affect OptiNose's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OptiNose's value and its price as these two are different measures arrived at by different means. Investors typically determine if OptiNose is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OptiNose's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.